Stewardship Health sale to private equity finalized for $245M

The August sale of Stewardship Health—a physician group once part of Steward Health Care—has been finalized, with new owner Rural Healthcare Group rebranding the network as Revere Medical. 

Rural Healthcare Group is owned by private equity firm Kinderhook Industries, and the purchase was finalized for $245 million in cash. As part of the deal, Rural Healthcare Group will also be rebranded as Revere Medical, forming a single consolidated entity with Stewardship. 

“Combining the organizations will allow Revere Medical to accelerate the impact of our operating model across more providers, patients and communities,” Benson Sloan, CEO of Revere Medical, said in a statement. “The next step is to integrate the two organizations while making further investments to bolster the delivery of care.”

Revere Medical plans to invest in Steward’s legacy infrastructure—both people and technology—but added that it will “ensure that care remains local so that patients can still access their existing providers, specialists and hospitals.” Before the buyout, Stewardship was made up of 3,500 primary and specialty care doctors who served patients nationwide. It’s not clear exactly how much the new Revere Medical plans to change personnel and operations.

“The Stewardship team is excited for this next chapter with Revere Medical as it provides a committed partner focused on quality care and improving the clinic experience for providers, clinic-teams and patients,” Joseph Weinstein, MD, President of Stewardship said in the statement.

Steward’s sullied reputation

The sale to Kinderhook was part of ongoing bankruptcy litigation involving Steward facilities nationwide. The company filed for bankruptcy in May and has been seeking buyers for all of its hospitals and clinics.

Steward had been at the center of multiple scandals related to its business operations pre-bankruptcy, including allegations it spent millions spying on critics. The DOJ is also investigating the organization over its ties to foreign governments

It’s also been reported the company paid a $719 million dividend to its former private equity owner, Cerberus Capital, despite Steward losing $300 million the same year. 

Chad Van Alstin Health Imaging Health Exec

Chad is an award-winning writer and editor with over 15 years of experience working in media. He has a decade-long professional background in healthcare, working as a writer and in public relations.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup